SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
He‐wei Jiang(Shanghai Jiao Tong University), Sheng‐ce Tao(Shanghai Jiao Tong University), Xue‐ning Wang(Shanghai Jiao Tong University), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Hong Chen(Shanghai Sixth People's Hospital), Yang Li(Union Hospital), Ze‐Guang Han(Shanghai Jiao Tong University), Jing Zhang(Shandong University), Hai‐nan Zhang(Shanghai Jiao Tong University), Jia Xie(Shanghai Jiao Tong University), Pei‐Hui Wang(Shandong University), Yun‐xiao Zheng(Shanghai Jiao Tong University), Qingfeng Meng(Shanghai Jiao Tong University)
Cited by 376
Related Papers
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling
|Signal Transduction and Targeted Therapy|2020|301
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu
|Journal of Clinical Virology|2020|185
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
|Cell Reports|2021|183
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules
|Signal Transduction and Targeted Therapy|2022|175